Skip to main content
. Author manuscript; available in PMC: 2019 Jul 8.
Published in final edited form as: Neurocrit Care. 2017 Apr;26(2):174–181. doi: 10.1007/s12028-016-0328-9

Table 1.

Patient characteristics

Variablesa Entire cohort (n = 341)

Male gender    192 (56.30)
Age, years 56.30 (42.53–68.30)
White race    198 (58.06)
Glasgow Coma Score on admission        6 (3–7)
Category/cause of brain injury
  Subarachnoid hemorrhage    128 (37.54)
  Intraparenchymal hemorrhage      80 (23.46)
  Traumatic brain injury      70 (20.53)
  Brain tumor      23 (6.74)
  Liver failure      10 (2.93)
  Intraventricular hemorrhage      10 (2.93)
  Otherb        9 (2.64)
  Cerebrovascular accident        8 (2.35)
  Subdural hemorrhage        5 (1.47)
ICP monitor type*
  Bolt      76 (22.29)
  Ventricular    266 (78.01)
  Neurovent        1 (0.29)
  Invasive ventilation time, days   3.23 (1.24–8.91)
  ICU length of stay, days 11.19 (6.23–17.05)
  Hospital LOS, days 16.00 (9.00–24.00)
  In-hospital mortality    103 (30.21)
  Number of recorded ICP measurements (per patient)      87 (48–120)

ICP intracranial pressure, LOS length of stay

*

Two patients had both an intraparenchymal hemorrhage and subarachnoid hemorrhage during their admission. An additional two patients were documented as switching between ventricular and bolt monitors during their ICU stay

a

Variables are presented as N (%) or median (IQR) depending on the type

b

Other includes anoxic brain injury post cardiac arrest, chronic small vessel infarct, meningitis, posterior reversible encephalopathy syndrome related to methylprednisolone-induced hypertension, septic thromboemboli, and hydrocephalus